Latest Compliance News

Invex Therapeutics reveals the collapse of confidential acquisition negotiations following shareholder unrest and potential board changes, clarifying recent unusual trading activity.

VEEM Limited has completed a $14 million placement to accelerate its growth in the defence sector, highlighted by a new 9-year manufacturing licence agreement with Northrop Grumman valued initially at US$33 million. This positions VEEM alongside major US defence contractors and signals a significant step into the expanding submarine and naval supply chains.

Aguia Resources has announced a one-for-ten entitlement issue to raise up to $4 million, including free attaching options, aimed at advancing its Santa Barbara Gold Project and supporting working capital.

InFocus Group Holdings has launched a dedicated iGaming business unit, aiming to capitalize on the booming $95 billion online gaming industry with key contracts and digital asset integration.

Wia Gold Limited has completed a Scoping Study for its Kokoseb Gold Project in Namibia, confirming its potential as a long-life, economically viable open pit mine with strong financial metrics and a clear path to development.

Metal Bank Limited has announced a non-renounceable entitlement offer to raise approximately $2.32 million, partially underwritten, to fund its Western Australia gold strategy and Queensland graphite exploration. The offer closes on 31 October 2025 and coincides with a strategic acquisition of gold assets from Hastings Technology Metals.

Southern Palladium has responded to an ASX price query denying undisclosed information behind its recent share price rise, instead pointing to positive commodity price trends and ongoing project developments.

Bio-Gene Technology Limited has addressed ASX concerns over the timing of its announcement on promising Flavocide efficacy data, confirming compliance with continuous disclosure rules after receiving final presentation materials from Purdue University.

Australian Clinical Labs has reached a $6.2 million settlement with the Australian Information Commissioner to resolve a Federal Court case stemming from a 2022 cyberattack on its newly acquired Medlab Pathology business.

OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.

Lode Resources has finalized the sale of its Webbs Consol silver project to Rapid Critical Metals, securing $3.75 million in cash, $8 million in shares, and a royalty stake, fueling its exploration push in silver and antimony.

Invictus Energy has responded to an ASX inquiry about unusual trading activity, clarifying that recent price and volume changes followed a disclosed deferral of a placement tied to a strategic joint venture.